Research Topics
| R KohliSummaryAffiliation: Tufts-New England Medical Center Country: USA Publications
|
Detail Information
Publications
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapyRakhi Kohli
Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA
Clin Infect Dis 41:864-72. 2005..Mortality trends among drug users in the era of highly active antiretroviral therapy (HAART) remain unclear...
Aging and HIV infectionRakhi Kohli
Division of Geographic Medicine and Infectious Disease, Department of Medicine, Tufts New England Medical Center, 750 Washington Street 41, Boston, MA 02111, USA
J Urban Health 83:31-42. 2006..In this paper, we discuss the health issues confronting HIV-infected older adults and areas for future research...
A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophyR Kohli
Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Department of Public Health and Family Medicine, Tufts University School of Medicine, Boston, MA 02111, USA
HIV Med 8:420-6. 2007....
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) studyRakhi Kohli
Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Clin Infect Dis 43:90-8. 2006..Interventions that improve HAART utilization and promote smoking cessation among HIV-infected women are warranted...
Fungal arthritis and osteomyelitisRakhi Kohli
Tufts University School of Medicine, Division of Geographic Medicine and Infectious Disease, Tufts-New England Medical Center, Boston, MA 02111, USA
Infect Dis Clin North Am 19:831-51. 2005..Given the rarity of this disease, treatment is not well defined, but reports of success with the use of azole antifungal agents, including itraconazole, fluconazole, voriconazole, and posaconazole, are promising...
